Sign Up | Log In | What is SocialPicks?

The Stock Idea & Analysis Community

SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.

Are you a stock guru?

Share picks & earn reputation

Biotech

Start Tracking Biotech - Add to Friends - Send Message

Community Rank: Analyst (163 pts) | Member since 10/02/2009

Picks Performance:

N/A

No percentile ranking
has been calculated.

What's this?

All-time Return -84.96% (in over 2 years)	Risk (SD) Conservative 0.00%	Sharpe Ratio N/A
Followers 1	Winning Picks 0 of 2	Total Views 14993

Overview

Stocks

Stats

Community

Widget

Last Activity: Added MBRX to bullish list on 10/11/09

Current Stock List:

Symbol	SP Sentiment	Return	Since
MBRX	N/A	n/a	10/11/09
IMGG		n/a	10/09/09
CXM		-84.32%	10/09/09
GOVX	N/A	n/a	10/02/09
ADXS	N/A	n/a	10/02/09
HEB		-85.59%	10/02/09

All-time Sectors of Interest

... View All >

Opinion & Analysis

Bullish on MBRX ... about MBRX 10/11/09
Buyout rumor! According to thestreet.com"Metabasis Therapeutics (MBRX Quote) jumped 19 cents, or 37.9%, to 71 cents after a Briefing.com report that the company may have found a buyer. Last month, t...

Pre-approval run for IMGG about IMGG 10/09/09
For the past few days, IMGG is performing quite well. In the last few days we saw profit taking as well huge buying. Considering the new group of investors at each price level, I think the pps may cros...

Bullish on CXM ... about CXM 10/09/09
CXM looks a strong buy. CXM plans to announce important results of a Phase-2 study anytime on or before October 14, 2009. Please follow the PR: "Cardium Therapeutics (NYSE Amex: CXM) announced plans...

Bullish on GOVX ... about GOVX 10/02/09
Buy!!

Bullish on ADXS ... about ADXS 10/02/09
Buy!!!

... View All >

Discussions

HEB - another opportunity to add more!! 10/02/09
I added more today. I hope other traders too.

IMGG may cross $5 after FDA approval 10/02/09
IMGG -----Highly Undervalued stock waiting for FDA approval. IMGG has prior FDA 510K approvals. Currently waiting for another FDA approval, which is likely to come WITHIN A MONTH or even earlier. IMGG may cross $1.50 during the pre approval run. Considering the advance demand of the product, after approval it’s possible to cross $5. There are other recent examples of stocks waiting for ...

People Following Biotech ...

mbmalone

Analyst

N/A

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.36%	531
2	Gerald Greene	18.14	+36.28%	286
3	stockmarketfunding.com	17.66	+23.07%	83
4	akiralegrand	13.47	+13.37%	69
5	anup2104	12.13	+132.16%	102

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
XOM	Exxon Mobil Corp
T	AT&T Inc
SIRI	Sirius Satellite Radio Inc
AMD	Advanced Micro Devices Inc
MO	Altria Group Inc
ETFC	E*Trade Financial Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

Stop Waiting for the Crash; Use a Regular Investment Plan
by Dan Caplinger (Fool.com) about SPY DJI

... more »

TODAY'S TOP PICKS

NUAN		Bullish on NUAN ... by jrmarketing2012
GPM		Bullish on GPM ... by jrmarketing2010
CAH		Bullish on CAH ... by jrmarketing2011
AUBN		Bullish on AUBN ... by jrmarketing2009
VRTX		Vertex Pharmaceuticals Inc (VRTX) sell before the mass sold - ?$ 4... by Yannis Maarten

... more »

Similarity to Me ?

Compare Your Portfolio With Biotech : Enter stocks you like & get new ideas daily:

Symbols, separated by space (e.g. AAPL GOOG MSFT)

More about Biotech

Investment Style:
Moderate [?]

Avg exp holding time:
827.43 days

Age: 30's	Occupation: Biotech Research
Location: NY

About Me:

Biotech researcher

Similar Portfolios

mbmalone (mbmalone) N/A 100%

Marian Filo (supratrade) 62% 50%

Mike Havrilla (mikehav) 73% 50%

biotech92 (biotech92) N/A 33%

robert haag (american2) N/A 33%

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.